drug · antibody
patient view →serplulimab
Phase 3updated 2mo agoby Shanghai Henlius Biotech Inc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and small cell lung carcinoma and 16 investigational indications.
targets
Programmed cell death protein 1
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that